These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2905000)

  • 1. Dopamine-mediated behaviour following chronic treatment with B-HT 920.
    Darmani NA; Sewell RD; Nicholls PJ
    J Pharm Pharmacol; 1988 Jul; 40(7):523-4. PubMed ID: 2905000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
    Chopra K; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1988; 294():46-55. PubMed ID: 2906798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
    Meltzer LT; Wiley JN; Williams AE; Heffner TG
    Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.
    Johansen PA; Clarkl D; White FJ
    Life Sci; 1988; 43(6):515-24. PubMed ID: 2900459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.
    Pichler L; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):180-2. PubMed ID: 6117802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-HT 920 and B-HT 958: presynaptic effects on electrically evoked 3H-dopamine release from slices of rat nucleus accumbens.
    Cichini G; Placheta P; Singer EA
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):28-31. PubMed ID: 2883584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Jun; 43(6):421-4. PubMed ID: 1681056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.
    Hjorth S; Carlsson A
    Psychopharmacology (Berl); 1987; 93(4):534-7. PubMed ID: 2893419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A; Kulkarni SK
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats.
    Pichler L; Pifl C; Hornykiewicz O; Kobinger W
    Eur J Pharmacol; 1987 Mar; 135(2):239-42. PubMed ID: 2884121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Feb; 43(2):131-3. PubMed ID: 1672900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole and yohimbine antagonize hypomotility, penile erection, stretching and yawning induced in rats by BHT 920, a selective dopamine autoreceptor agonist.
    Ferrari F; Mangiafico V; Tartoni P; Tampieri A
    Pharmacol Res Commun; 1988 Sep; 20(9):827-37. PubMed ID: 2902650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
    Pifl C; Pichler L; Kobinger W; Hornykiewicz O
    Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.